Page last updated: 2024-12-08
1,3,6,8-tetrabromocarbazole
Description
## 1,3,6,8-Tetrabromocarbazole: A Versatile Building Block for Research
1,3,6,8-Tetrabromocarbazole is a halogenated derivative of carbazole, a heterocyclic aromatic compound with a nitrogen atom incorporated in a three-ring system. The tetrabromo prefix signifies the presence of four bromine atoms at positions 1, 3, 6, and 8 on the carbazole ring.
**Why is it important for research?**
This compound is important for various research fields due to its unique properties and versatility:
* **Organic Electronics:** 1,3,6,8-Tetrabromocarbazole serves as a versatile building block for synthesizing organic semiconductors. Its high electron affinity and good thermal stability make it ideal for applications in organic field-effect transistors (OFETs) and organic light-emitting diodes (OLEDs).
* **Photovoltaic Devices:** The compound's electron-withdrawing properties and planar structure contribute to efficient charge transport in organic solar cells. This makes it a promising candidate for improving the performance of organic photovoltaic devices.
* **Materials Science:** 1,3,6,8-Tetrabromocarbazole exhibits excellent properties like thermal stability and high refractive index. These characteristics make it suitable for applications in optical and optoelectronic devices.
* **Bioactive Compounds:** The compound's bromine atoms can be modified or replaced with other functional groups, leading to the development of novel bioactive molecules with potential applications in medicine and agriculture.
**Current Research:**
Researchers are actively investigating the potential of 1,3,6,8-Tetrabromocarbazole in various areas, including:
* **Synthesis of novel carbazole-based polymers:** New polymers based on this compound exhibit improved properties, enhancing their potential in electronics and photonics.
* **Modification and functionalization:** Researchers are exploring the substitution of bromine atoms with other functional groups to enhance solubility, stability, and bioactivity.
* **Fabrication of new devices:** The compound is being used to develop innovative and efficient devices like organic solar cells, sensors, and memory devices.
In conclusion, 1,3,6,8-Tetrabromocarbazole is a crucial molecule for research due to its multifaceted properties. It offers promising opportunities for advancements in organic electronics, materials science, and even medicinal chemistry. Continued research will further explore its potential and contribute to various scientific and technological breakthroughs.
1,3,6,8-tetrabromocarbazole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 258744 |
SCHEMBL ID | 16672373 |
MeSH ID | M0497595 |
Synonyms (22)
Synonym |
nsc88024 |
55119-09-0 |
nsc-88024 |
STK726736 |
1,3,6,8-tetrabromo-9h-carbazole |
1,3,6,8-tetrabromocarbazole |
AKOS001588908 |
FT-0674940 |
T2932 |
9h-carbazole, 1,3,6,8-tetrabromo- |
CCG-234116 |
SCHEMBL16672373 |
SR-01000397424-1 |
sr-01000397424 |
DTXSID30293246 |
mfcd00218272 |
DS-9085 |
YSZC977 |
C75580 |
A870270 |
CS-0147309 |
c12h5br4n |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 4 (44.44) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.00
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 13.00 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 5.31 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |